• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶逆转录酶基因存在两种不同突变的两个家族中先天性角化不良的复杂遗传模式。

Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene.

作者信息

Du Hong-Yan, Pumbo Elena, Manley Peter, Field Joshua J, Bayliss Susan J, Wilson David B, Mason Philip J, Bessler Monica

机构信息

Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.

出版信息

Blood. 2008 Feb 1;111(3):1128-30. doi: 10.1182/blood-2007-10-120907. Epub 2007 Nov 27.

DOI:10.1182/blood-2007-10-120907
PMID:18042801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2214749/
Abstract

Heterozygous mutations in the telomerase components TERT, the reverse transcriptase, and TERC, the RNA template, cause autosomal dominant dyskeratosis congenita due to telomere shortening. Anticipation, whereby the disease severity increases in succeeding generations due to inheritance of shorter telomeres, is a feature of this condition. Here we describe 2 families in which 2 TERT mutations are segregating. Both families contain compound heterozygotes. In one case the proband is homozygous for a novel mutation causing a P704S substitution, while his father's second allele encodes an H412Y mutation. The proband in the second family has mutant alleles Y846C and H876Q. Transfection studies show codominant expression of the mutated alleles with no evidence of a dominant negative effect or of intragenic complementation. Thus in these families the expression of both TERT alleles and the inherited telomere length contribute to the clinical phenotype.

摘要

端粒酶组分中的杂合突变,即逆转录酶TERT和RNA模板TERC的突变,会因端粒缩短导致常染色体显性遗传性先天性角化不良。疾病严重程度会因后代继承更短的端粒而在连续几代中增加,这种现象称为遗传早现,是这种疾病的一个特征。在此,我们描述了2个家系,其中2种TERT突变正在分离。两个家系均包含复合杂合子。在一个病例中,先证者对导致P704S替换的新突变呈纯合状态,而他父亲的第二个等位基因编码H412Y突变。第二个家系的先证者具有突变等位基因Y846C和H876Q。转染研究显示突变等位基因的共显性表达,没有显性负效应或基因内互补的证据。因此,在这些家系中,两个TERT等位基因的表达以及遗传的端粒长度均对临床表型有影响。

相似文献

1
Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene.端粒酶逆转录酶基因存在两种不同突变的两个家族中先天性角化不良的复杂遗传模式。
Blood. 2008 Feb 1;111(3):1128-30. doi: 10.1182/blood-2007-10-120907. Epub 2007 Nov 27.
2
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.由于TERC基因突变导致的先天性角化不良家族中,疾病预期与端粒逐渐缩短相关。
Nat Genet. 2004 May;36(5):447-9. doi: 10.1038/ng1346. Epub 2004 Apr 18.
3
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.常染色体隐性先天性角化不良和霍耶拉尔-赫雷戴松综合征中的端粒酶逆转录酶纯合突变。
Blood. 2007 Dec 15;110(13):4198-205. doi: 10.1182/blood-2006-12-062851. Epub 2007 Sep 4.
4
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.先天性角化不良症皮肤角质形成细胞的增殖缺陷可通过端粒酶逆转录酶(TERT)的表达或通过表达乳头瘤病毒 E6/E7 或端粒酶 RNA 成分 TERC 来激活内源性端粒酶来纠正。
Exp Dermatol. 2010 Mar;19(3):279-88. doi: 10.1111/j.1600-0625.2009.00916.x. Epub 2009 Jun 23.
5
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.端粒酶逆转录酶单倍剂量不足导致常染色体显性遗传性先天性角化不良的遗传早现。
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15960-4. doi: 10.1073/pnas.0508124102. Epub 2005 Oct 24.
6
The effect of TERC haploinsufficiency on the inheritance of telomere length.TERC单倍剂量不足对端粒长度遗传的影响。
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17119-24. doi: 10.1073/pnas.0505318102. Epub 2005 Nov 11.
7
Dyskeratosis congenita: telomerase, telomeres and anticipation.先天性角化不良:端粒酶、端粒与遗传早现
Curr Opin Genet Dev. 2005 Jun;15(3):249-57. doi: 10.1016/j.gde.2005.04.004.
8
Heterozygous telomerase deficiency in mouse and man: when less is definitely not more.小鼠和人类中的杂合性端粒酶缺乏:何时少绝对并非多。
Cell Cycle. 2004 Sep;3(9):1127-9. Epub 2004 Sep 23.
9
Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.先天性角化不良:端粒酶复合体突变的多样临床表现。
Biochimie. 2008 Jan;90(1):122-30. doi: 10.1016/j.biochi.2007.07.017. Epub 2007 Jul 31.
10
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.端粒酶组分NHP2的突变会导致早衰综合征先天性角化不良。
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8073-8. doi: 10.1073/pnas.0800042105. Epub 2008 Jun 3.

引用本文的文献

1
Polygenic modifiers impact penetrance and expressivity in telomere biology disorders.多基因修饰因子影响端粒生物学障碍中的外显率和表现度。
J Clin Invest. 2025 Jun 3. doi: 10.1172/JCI191107.
2
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders.端粒生物学障碍中的适应性和不适应性克隆性造血
Curr Hematol Malig Rep. 2024 Feb;19(1):35-44. doi: 10.1007/s11899-023-00719-2. Epub 2023 Dec 14.
3
Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder.复合杂合 TERT 突变的功能相互作用导致严重的端粒生物学紊乱。
Blood Adv. 2022 Jun 28;6(12):3779-3791. doi: 10.1182/bloodadvances.2022007029.
4
Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.罕见病中的多系统表现:先天性角化不良症的经验。
Genes (Basel). 2022 Mar 11;13(3):496. doi: 10.3390/genes13030496.
5
Severe therapy-related toxicities after treatment for Hodgkin lymphoma due to a pathogenic TERT variant and shortened telomeres.由于致病性 TERT 变异和端粒缩短导致霍奇金淋巴瘤治疗后的严重治疗相关毒性。
Pediatr Blood Cancer. 2019 Aug;66(8):e27779. doi: 10.1002/pbc.27779. Epub 2019 May 2.
6
MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia.MECOM 相关综合征:一种具有巨核细胞减少性血小板减少症的异质性遗传性骨髓衰竭综合征。
Blood Adv. 2018 Mar 27;2(6):586-596. doi: 10.1182/bloodadvances.2018016501.
7
Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.北欧患者中与端粒相关疾病的基因检测相关的新型变异。
Eur J Hum Genet. 2018 Jun;26(6):858-867. doi: 10.1038/s41431-018-0112-8. Epub 2018 Feb 26.
8
Insights from human genetic studies of lung and organ fibrosis.人类肺部和器官纤维化遗传研究的新见解。
J Clin Invest. 2018 Jan 2;128(1):36-44. doi: 10.1172/JCI93556.
9
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.一项评估罕见基因变异在肺纤维化中作用的外显子组测序研究。
Am J Respir Crit Care Med. 2017 Jul 1;196(1):82-93. doi: 10.1164/rccm.201610-2088OC.
10
Pulmonary fibrosis in the era of stratified medicine.分层医学时代的肺纤维化
Thorax. 2016 Dec;71(12):1154-1160. doi: 10.1136/thoraxjnl-2016-209172. Epub 2016 Oct 31.

本文引用的文献

1
Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome.5p-综合征患者的端粒酶逆转录酶单倍剂量不足与端粒长度
Aging Cell. 2007 Oct;6(5):689-97. doi: 10.1111/j.1474-9726.2007.00324.x.
2
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.常染色体隐性先天性角化不良和霍耶拉尔-赫雷戴松综合征中的端粒酶逆转录酶纯合突变。
Blood. 2007 Dec 15;110(13):4198-205. doi: 10.1182/blood-2006-12-062851. Epub 2007 Sep 4.
3
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.常染色体隐性遗传性先天性角化不良中的遗传异质性,其中一种亚型由端粒酶相关蛋白NOP10突变引起。
Hum Mol Genet. 2007 Jul 1;16(13):1619-29. doi: 10.1093/hmg/ddm111. Epub 2007 May 16.
4
The effect of TERC haploinsufficiency on the inheritance of telomere length.TERC单倍剂量不足对端粒长度遗传的影响。
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17119-24. doi: 10.1073/pnas.0505318102. Epub 2005 Nov 11.
5
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.端粒酶逆转录酶单倍剂量不足导致常染色体显性遗传性先天性角化不良的遗传早现。
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15960-4. doi: 10.1073/pnas.0508124102. Epub 2005 Oct 24.
6
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita.先天性角化不良患者端粒酶RNA模板基因(TERC)2个变异等位基因的鉴定及功能特征分析
Blood. 2005 Aug 15;106(4):1246-52. doi: 10.1182/blood-2005-01-0247. Epub 2005 May 10.
7
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.骨髓衰竭患者端粒酶逆转录酶成分(TERT)的突变。
Blood Cells Mol Dis. 2005 May-Jun;34(3):257-63. doi: 10.1016/j.bcmd.2004.12.008.
8
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.再生障碍性贫血中端粒酶逆转录酶基因(TERT)的突变
N Engl J Med. 2005 Apr 7;352(14):1413-24. doi: 10.1056/NEJMoa042980.
9
Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency.在先天性角化不良和再生障碍性贫血中发现的杂合性端粒酶RNA突变通过单倍剂量不足降低端粒酶活性。
Blood. 2004 Dec 15;104(13):3936-42. doi: 10.1182/blood-2004-05-1829. Epub 2004 Aug 19.
10
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.由于TERC基因突变导致的先天性角化不良家族中,疾病预期与端粒逐渐缩短相关。
Nat Genet. 2004 May;36(5):447-9. doi: 10.1038/ng1346. Epub 2004 Apr 18.